News

Pharmabiz1h
Orion & Criceto signs agreement to develop and commercialise Aporon, an innovative apomorphine spray to treat OFF episodes in Parkinson’s disease
Orion & Criceto signs agreement to develop and commercialise Aporon, an innovative apomorphine spray to treat OFF episodes in Parkinson’s disease: Espoo, Finland Monday, April 2 ...
Pharmabiz1h
Medanta to invest Rs. 500 crore for healthcare in North East with a 400-bed super specialty hospital in Guwahati
Medanta to invest Rs. 500 crore for healthcare in North East with a 400-bed super specialty hospital in Guwahati: Our Bureau, Bengaluru Monday, April 28, 2025, 16:45 Hrs [IST] Glo ...
Pharmabiz2h
EMA grants conditional marketing authorization to Italfarmaco’s Duvyzat to treat Duchenne muscular dystrophy
EMA grants conditional marketing authorization to Italfarmaco’s Duvyzat to treat Duchenne muscular dystrophy: Amsterdam, The Netherlands Monday, April 28, 2025, 16:00 Hrs [IST] ...
Pharmabiz4h
Fortis’ Robot-Assisted Bilateral Knee Replacement with VELYS equips patient to regain mobility after 5 years
Fortis’ Robot-Assisted Bilateral Knee Replacement with VELYS equips patient to regain mobility after 5 years: Our Bureau, Bengaluru Monday, April 28, 2025, 14:15 Hrs [IST] Forti ...
Pharmabiz4h
Zydus Lifesciences inks purchase pact with PAI Partners and others to acquire a majority stake in Amplitude Surgical SA
Zydus Lifesciences inks purchase pact with PAI Partners and others to acquire a majority stake in Amplitude Surgical SA: Our Bureau, Bengaluru Monday, April 28, 2025, 13:40 Hrs [I ...
Pharmabiz4h
Ono Pharma inks agreement with Seikagaku to co-develop & market Gel-One to treat osteoarthritis in Japan
Ono Pharma inks agreement with Seikagaku to co-develop & market Gel-One to treat osteoarthritis in Japan: Osaka, Japan Monday, April 28, 2025, 14:00 Hrs [IST] Ono Pharmaceutical C ...
Pharmabiz3h
Keymed Biosciences’ CM518D1, a CDH17-targeted ADC receives IND approval from China NMPA to treat solid tumours
Keymed Biosciences’ CM518D1, a CDH17-targeted ADC receives IND approval from China NMPA to treat solid tumours: Chengdu, China Monday, April 28, 2025, 15:00 Hrs [IST] Keymed Bio ...
Pharmabiz4h
ISRO and SCTIMST sign MoU in space medicine
ISRO has signed the 'Framework Memorandum of Understanding on Cooperation in Space Medicine' with Sree Chitra Tirunal Institute for Medical Sciences & Technology (SCTIMST). The partnership marks a ...
Pharmabiz5h
UK MHRA grants marketing authorization to Bayer’s acoramidis to treat wild-type or variant transthyretin amyloidosis in adults with cardiomyopathy
UK MHRA grants marketing authorization to Bayer’s acoramidis to treat wild-type or variant transthyretin amyloidosis in adults with cardiomyopathy: United Kingdom Monday, April ...
Pharmabiz5h
Telangana govt changes the title of pharmacist into ‘pharmacy officer’ at the entry level
Telangana govt changes the title of pharmacist into ‘pharmacy officer’ at the entry level: Our Bureau, Chennai Monday, April 28, 2025, 13:30 Hrs [IST] The Government of Telang ...
Pharmabiz7h
EMA recommends marketing approval for Amgen Europe’s Tepezza to treat adults with moderate to severe thyroid eye disease
EMA recommends marketing approval for Amgen Europe’s Tepezza to treat adults with moderate to severe thyroid eye disease: Amsterdam, The Netherlands Monday, April 28, 2025, 11:0 ...
Pharmabiz6h
China NMPA approves InnoCare Pharma’s orelabrutinib for first-line treatment of patients with CLL/SLL
China NMPA approves InnoCare Pharma’s orelabrutinib for first-line treatment of patients with CLL/SLL: Beijing Monday, April 28, 2025, 12:00 Hrs [IST] InnoCare Pharma, a leading ...